Please try another search
For the nine months ended 31 December 2019, Applied Biosciences Corp revenues increased 32% to $625K. Net loss increased 7% to $2.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects FV Adjustments of Financial Investments decrease from $405K (income) to $327K (expense), Depreciation and Amortization increase from $1K to $120K (expense).
Period Ending: | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|
Total Revenue | 0.17 | 0.24 | 0.21 | 0.23 |
Gross Profit | 0.12 | 0.15 | 0.11 | 0.15 |
Operating Income | -0.97 | -0.82 | -0.48 | -0.41 |
Net Income | -1.35 | -0.78 | -0.42 | -0.23 |
Period Ending: | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|
Total Assets | 3.42 | 3.48 | 3.52 | 3.65 |
Total Liabilities | 3.19 | 2.3 | 1.73 | 1.52 |
Total Equity | 0.23 | 1.18 | 1.79 | 2.13 |
Period Ending: | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.82 | -0.77 | -0.4 | -0.91 |
Cash From Investing Activities | 0 | -0.71 | ||
Cash From Financing Activities | 0.79 | 0.79 | 0.39 | 1.6 |
Net Change in Cash | -0.03 | 0.03 | -0.01 | -0.01 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review